Elixinol Wellness has been growing earnings at an average annual rate of 64.4%, while the Personal Products industry saw earnings growing at 10.5% annually. Revenues have been growing at an average rate of 8% per year.
Key information
64.45%
Earnings growth rate
83.11%
EPS growth rate
Personal Products Industry Growth
8.70%
Revenue growth rate
8.04%
Return on equity
-73.81%
Net Margin
-35.48%
Last Earnings Update
31 Dec 2025
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Elixinol Wellness makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
DB:E8M Revenue, expenses and earnings (AUD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Dec 25
16
-5
10
0
30 Sep 25
16
-4
10
0
30 Jun 25
16
-2
9
0
31 Mar 25
15
-2
9
0
31 Dec 24
15
-2
9
0
30 Sep 24
13
-4
9
0
30 Jun 24
12
-7
9
0
31 Mar 24
10
-7
9
0
31 Dec 23
8
-8
9
0
30 Sep 23
8
-7
10
0
30 Jun 23
7
-7
10
0
31 Mar 23
7
-9
11
0
31 Dec 22
7
-11
13
0
30 Sep 22
7
-12
14
0
30 Jun 22
8
-13
16
0
31 Mar 22
9
-15
17
0
31 Dec 21
9
-17
19
0
30 Sep 21
11
-21
20
0
30 Jun 21
12
-25
22
0
31 Mar 21
13
-65
25
0
31 Dec 20
15
-105
29
0
30 Jun 20
21
-161
37
0
31 Mar 20
26
-121
38
0
31 Dec 19
31
-80
39
0
30 Jun 19
35
-10
29
0
31 Mar 19
34
-5
23
0
31 Dec 18
32
0
17
0
Quality Earnings: E8M is currently unprofitable.
Growing Profit Margin: E8M is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: E8M is unprofitable, but has reduced losses over the past 5 years at a rate of 64.4% per year.
Accelerating Growth: Unable to compare E8M's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: E8M is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (2.8%).
Return on Equity
High ROE: E8M has a negative Return on Equity (-73.81%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/07 10:34
End of Day Share Price
2026/07/07 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Elixinol Wellness Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.